Ernexa Therapeutics Inc.

NASDAQ: ERNA · Real-Time Price · USD
1.23
0.05 (4.24%)
At close: Sep 16, 2025, 2:06 PM

Ernexa Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.81 -6.62 -6 -22.14
PEG Ratio
0.05 0.13 0.07 -0.01
PS Ratio
215.18 2.11K n/a n/a
PB Ratio
73.62 64.25 12.17 106.20
P/FCF Ratio
-7.73 -7.02 -6.93 -114.56
P/OCF Ratio
-7.91 -7.03 -7.03 -115.31
OCF/S Ratio
-27.21 -300.12 n/a n/a
Debt / Equity Ratio
0.40 18.74 0.34 0.11
Quick Ratio
0.80 1.46 1.79 5.10
Current Ratio
0.80 1.46 1.79 5.10
Asset Turnover
0.11 0.00 n/a n/a
Interest Coverage
-2.32 -34.42 -898.23 -370.66
Return on Equity
-26.18 -9.7 -2.03 -4.8
Return on Assets
-8.45 -0.44 -1.1 -3.77
Return on Invested Capital
-6.18 -0.45 -1.62 -0.93
Dividend Yield
0.00 0.00 0.00 0.00
Payout Ratio
-0.00 -0.00 -0.00 -0.00
Gross Profit Margin
0.84 -2.47 n/a n/a
Net Profit Margin
-76.53 -318.65 n/a n/a
Pretax Profit Margin
-76.48 -318.69 n/a n/a
Operating Profit Margin
-26.93 -310.81 n/a n/a
FCF Margin
-27.84 -300.4 n/a n/a
EBITDA Margin
-62.06 -293.15 n/a n/a